Loading clinical trials...
Loading clinical trials...
Extension Study for Patients Who Completed GENA-05 (NuProtect)- to Investigate Immunogenicity, Efficacy and Safety of Treatment With Human-cl rhFVIII
Conditions
Interventions
Human-cl rhFVIII
Locations
15
United States
UC Davis Medical Center
Sacramento, California, United States
University of Alberta
Edmonton, Alberta, Canada
BC Children's Hospital
Vancouver, British Columbia, Canada
McMaster Children's Hospital
Hamilton, Ontario, Canada
Hospital for Sick Children
Toronto, Canada
Hopital de la Timone
Marseille, France
Start Date
April 1, 2014
Primary Completion Date
December 27, 2018
Completion Date
December 27, 2018
Last Updated
January 19, 2021
NCT05935358
NCT06703606
NCT05981274
NCT06938542
NCT07446010
NCT06136507
Lead Sponsor
Octapharma
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions